Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets
Abstract
SummaryPlatelet microparticles (PMPs) are small vesicles released from blood platelets upon activation. The procoagulant activity of PMPs has been previously mainly characterized by theirability to bind coagulation factors VIII and Va in reconstructed systems. It can be supposed that PMPs can contribute to the development of thrombotic complications in the pathologic states associated with the increase of their blood concentration. In this study we compared procoagulant properties of calcium ionophore A23187-activated platelets and PMPs using several in-vitro models of hemostasis. Surface densities of phosphatidylserine, CD61, CD62P and factor X bound per surface area unit were determined by flow cytometry. They were 2.7-, 8.4-, 4.3-, and 13-fold higher for PMPs than for activated platelets, respectively. Spatial clot growth rate (Vclot) in the reaction-diffus ion experimental model and endogenous thrombin potential (ETP) were determined in plasma, which was depleted of phospholipid cell surfaces by ultra-centrifugation and supplemented with activated platelets or PMPs at different concentrations. Both Vcllot and ETP rapidly increased with the increase of PMP or platelet concentration until saturation was reached. The plateau values of Vclot and ETP for activated platelets and PMPs were similar. In both assays, the procoagulant activity of one PMP was almost equal to that of one activated platelet despite at least two-orders-of-magnitude difference in their surface areas. This suggests that the PMP surface is approximately 50- to 100-fold more procoagulant than the surface of activated platelets.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Key Biomarkers
Cited By (7)
- Microparticles and acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology · 2012
- Microparticles: biomarkers and beyondClinical Science · 2013
- Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicineBlood Reviews · 2014
- Microparticles in health and diseaseJournal of Veterinary Internal Medicine · 2013
- Thrombosis, platelets, microparticles and PAH: more than a clotDrug Discovery Today · 2014
- Red blood cell microparticles: clinical relevanceTransfusion Medicine and Hemotherapy · 2012
- Gateway to Understanding Microparticles: Standardized Isolation and Identification of Plasma Membrane-Derived VesiclesNanomedicine · 2013
Related Papers
- A Transcriptomic Fingerprint for Parkinson's Disease Found in Patients with Chronic Inflammatory Response Syndrome: Implications for Diagnosis, Treatment and PreventionMedical Research Archives · 2024 · 2 shared tags
- Chronic Diarrhea and Weight Loss in an 18-month-old BoyPediatrics in Review · 2021 · 2 shared tags
- Consequences of Aging on BoneAging and Disease · 2023 · 2 shared tags
- Melanocortin 1 Receptor Deficiency in Hematopoietic Cells Promotes the Expansion of Inflammatory Leukocytes in Atherosclerotic MiceFrontiers in Immunology · 2021 · 2 shared tags
- Altered Cytokine Response of Human Brain Endothelial Cells after Stimulation with Malaria Patient PlasmaCells · 2021 · 2 shared tags
- A Novel Therapeutic Approach to Parkinson's Disease: Using Transcriptomics to Identify Unique Patterns of Gene Expression including 'Triple Positives,' Toll receptors, and Endotoxin ExposureMedical Research Archives · 2025 · 2 shared tags